2nd Generation Core Inhibitor

Multiple different classes of Core Inhibitors with distinguishing chemical and pharmacological properties compared to NVR 3-778 have been optimized. A 2nd generation Core Inhibitor candidate will be advanced to pre-clinical development in 2H2014.